MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia

Ebert, 2004, Genomic approaches to hematologic malignancies., Blood, 104, 923, 10.1182/blood-2004-01-0274 Valk, 2005, Gene expression profiling in acute myeloid leukemia., Curr Opin Hematol, 12, 76, 10.1097/01.moh.0000149610.14438.9a Valk, 2004, Prognostically useful gene-expression profiles in acute myeloid leukemia., N Engl J Med, 350, 1617, 10.1056/NEJMoa040465 Bullinger, 2005, Gene expression profiling in acute myeloid leukemia., J Clin Oncol, 23, 6296, 10.1200/JCO.2005.05.020 Bullinger, 2004, Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia., N Engl J Med, 350, 1605, 10.1056/NEJMoa031046 Grimwade, 2001, The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial., Blood, 98, 1312, 10.1182/blood.V98.5.1312 Slovak, 2000, Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study., Blood, 96, 4075, 10.1182/blood.V96.13.4075 Byrd, 2002, Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)., Blood, 100, 4325, 10.1182/blood-2002-03-0772 Dohner, 2005, Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations., Blood, 106, 3740, 10.1182/blood-2005-05-2164 Thiede, 2006, Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)., Blood, 107, 4011, 10.1182/blood-2005-08-3167 Frohling, 2002, Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm., Blood, 100, 4372, 10.1182/blood-2002-05-1440 Preudhomme, 2002, Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)., Blood, 100, 2717, 10.1182/blood-2002-03-0990 Barjesteh van Waalwijk van Doorn-Khosrovani, 2003, Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML., Hematol J, 4, 31, 10.1038/sj.thj.6200216 Falini, 2007, Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features., Blood, 109, 874, 10.1182/blood-2006-07-012252 Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function., Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 Plasterk, 2006, Micro RNAs in animal development., Cell, 124, 877, 10.1016/j.cell.2006.02.030 Lu, 2005, MicroRNA expression profiles classify human cancers., Nature, 435, 834, 10.1038/nature03702 Kent, 2006, A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes., Oncogene, 25, 6188, 10.1038/sj.onc.1209913 Xi, 2006, Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer., Clin Cancer Res, 12, 2014, 10.1158/1078-0432.CCR-05-1853 Cummins, 2006, Implications of micro-RNA profiling for cancer diagnosis., Oncogene, 25, 6220, 10.1038/sj.onc.1209914 Cummins, 2006, The colorectal microRNAome., Proc Natl Acad Sci U S A, 103, 3687, 10.1073/pnas.0511155103 Iorio, 2005, MicroRNA gene expression deregulation in human breast cancer., Cancer Res, 65, 7065, 10.1158/0008-5472.CAN-05-1783 Takamizawa, 2004, Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival., Cancer Res, 64, 3753, 10.1158/0008-5472.CAN-04-0637 Calin, 2005, A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia., N Engl J Med, 353, 1793, 10.1056/NEJMoa050995 Hayashita, 2005, A polycistronic microRNA cluster, miR-17–92, is overexpressed in human lung cancers and enhances cell proliferation., Cancer Res, 65, 9628, 10.1158/0008-5472.CAN-05-2352 Kluiver, 2007, Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma., Oncogene, 26, 3769, 10.1038/sj.onc.1210147 Eis, 2005, Accumulation of miR-155 and BIC RNA in human B cell lymphomas., Proc Natl Acad Sci U S A, 102, 3627, 10.1073/pnas.0500613102 Debernardi, 2007, MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis., Leukemia, 21, 912, 10.1038/sj.leu.2404605 Mi, 2007, MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia., Proc Natl Acad Sci U S A, 104, 19971, 10.1073/pnas.0709313104 Isken, 2008, Identification of acute myeloid leukaemia associated microRNA expression patterns., Br J Haematol, 140, 153, 10.1111/j.1365-2141.2007.06915.x Chen, 2005, Real-time quantification of microRNAs by stem-loop RT-PCR., Nucleic Acids Res, 33, e179, 10.1093/nar/gni178 Lowenberg, 1997, Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative Group., Blood, 90, 2952 Lowenberg, 2003, Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia., N Engl J Med, 349, 743, 10.1056/NEJMoa025406 Ossenkoppele, 2004, The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients., Blood, 103, 2908, 10.1182/blood-2003-07-2195 Verhaak, 2005, Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance., Blood, 106, 3747, 10.1182/blood-2005-05-2168 Lao, 2007, Real time PCR profiling of 330 human micro-RNAs., Biotechnol J, 2, 33, 10.1002/biot.200600119 Vandesompele, 2002, Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes., Genome Biol, 3, 10.1186/gb-2002-3-7-research0034 Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method., Methods, 25, 402, 10.1006/meth.2001.1262 National Center for Biotechnology Information Gene Expression Omnibus. Accessed March 12, 2008 http://www.ncbi.nlm.nih.gov/geo/ Verhaak, 2006, HeatMapper: powerful combined visualization of gene expression profile correlations, genotypes, phenotypes and sample characteristics., BMC Bioinformatics, 7, 337, 10.1186/1471-2105-7-337 Carey, 2005, Network structures and algorithms in Bioconductor., Bioinformatics, 21, 135, 10.1093/bioinformatics/bth458 Tibshirani, 2002, Diagnosis of multiple cancer types by shrunken centroids of gene expression., Proc Natl Acad Sci U S A, 99, 6567, 10.1073/pnas.082099299 Golub, 1999, Molecular classification of cancer: class discovery and class prediction by gene expression monitoring., Science, 286, 531, 10.1126/science.286.5439.531 Bullinger, 2007, Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemia., Blood, 110, 1291, 10.1182/blood-2006-10-049783 Shell, 2007, Let-7 expression defines two differentiation stages of cancer., Proc Natl Acad Sci U S A, 104, 11400, 10.1073/pnas.0704372104 Zhang, 2007, Detection of let-7a microRNA by real-time PCR in gastric carcinoma., World J Gastroenterol, 13, 2883, 10.3748/wjg.v13.i20.2883 Lee, 2007, The tumor suppressor microRNA let-7 represses the HMGA2 oncogene., Genes Dev, 21, 1025, 10.1101/gad.1540407 Brueckner, 2007, The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function., Cancer Res, 67, 1419, 10.1158/0008-5472.CAN-06-4074 Johnson, 2005, RAS is regulated by the let-7 microRNA family., Cell, 120, 635, 10.1016/j.cell.2005.01.014 Yanaihara, 2006, Unique microRNA molecular profiles in lung cancer diagnosis and prognosis., Cancer Cell, 9, 189, 10.1016/j.ccr.2006.01.025 Schubbert, 2007, Hyperactive Ras in developmental disorders and cancer., Nat Rev Cancer, 7, 295, 10.1038/nrc2109 Bacher, 2006, Implications of NRAS mutations in AML: a study of 2502 patients., Blood, 107, 3847, 10.1182/blood-2005-08-3522 Valk, 2004, Second hit mutations in the RTK/RAS signaling pathway in acute myeloid leukemia with inv(16) [letter]., Haematologica, 89, 106 Saito, 2006, Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells., Cancer Cell, 9, 435, 10.1016/j.ccr.2006.04.020 Alcalay, 2005, Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance., Blood, 106, 899, 10.1182/blood-2005-02-0560 Baldus, 2007, Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review., Br J Haematol, 137, 387, 10.1111/j.1365-2141.2007.06566.x Wilson, 2006, Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction., Blood, 108, 685, 10.1182/blood-2004-12-4633 Yekta, 2004, MicroRNA-directed cleavage of HOXB8 mRNA., Science, 304, 594, 10.1126/science.1097434 Kluiver, 2005, BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas., J Pathol, 207, 243, 10.1002/path.1825 Thai, 2007, Regulation of the germinal center response by microRNA-155., Science, 316, 604, 10.1126/science.1141229 Rodriguez, 2007, Requirement of bic/microRNA-155 for normal immune function., Science, 316, 608, 10.1126/science.1139253 Georgantas, 2006, MicroRNA hsa-mir-155 blocks myeloid and erythroid differentiation of human CD34+ cells [abstract]., ASH Annual Meeting Abstracts, 108, 1337 Zhu, 2007, MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1)., J Biol Chem, 282, 14328, 10.1074/jbc.M611393200 Asangani, MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer., Oncogene Meng, 2007, MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer., Gastroenterology, 133, 647, 10.1053/j.gastro.2007.05.022 Yilmaz, 2006, Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells., Nature, 441, 475, 10.1038/nature04703 Zhang, 2006, PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention., Nature, 441, 518, 10.1038/nature04747